BIOGEN INC (BIIB) Institutional Ownership Changes & 13F Activity
BIOGEN INC (BIIB) institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions among tracked filers. Notable filers include Sequoia Financial Advisors, Causeway Capital Management, Renaissance Technologies LLC, Hillman Value Fund, and Parnassus Endeavor Fund.
| Portfolio quarter | Name | Type | Quantity | Remaining | Reported stock balance |
|---|---|---|---|---|---|
| Q1 2022 | Longleaf Partners | Sell | -15,561 | 842,962 | $177,528 |
| Q1 2022 | Hillman Value Fund | Buy | 15,488 | 42,679 | $8,988 |
| Q1 2022 | Hancock Classic Value | Sell | -473 | 2,384 | $502 |
| Q4 2021 | Longleaf Partners | Buy | 254,633 | 858,523 | $205,977 |
| Q4 2021 | Renaissance Technologies LLC | Buy | 92,100 | 1,073,807 | $257,628 |
| Q4 2021 | Hillman Value Fund | Sell | -1,098 | 27,191 | $6,523 |
| Q3 2021 | Renaissance Technologies LLC | Sell | -348,296 | 981,707 | $277,813 |
| Q3 2021 | Hillman Value Fund | Buy | 1,050 | 28,289 | $8,005 |
| Q2 2021 | Renaissance Technologies LLC | Sell | -608,159 | 1,330,003 | $460,540 |
| Q2 2021 | Parnassus Endeavor Fund | Buy | 137,641 | 452,053 | $156,532 |
| Q2 2021 | Miller Value Partners | Buy | 79,493 | 79,493 | $27,526 |
| Q2 2021 | Hillman Value Fund | Sell | -50 | 27,239 | $9,432 |
| Q2 2021 | Muhlenkamp & Co | Buy | 34 | 18,218 | $6,308 |
| Q1 2021 | Renaissance Technologies LLC | Sell | -1,099,600 | 1,938,162 | $542,201 |
| Q1 2021 | Longleaf Partners | Buy | 603,890 | 603,890 | $168,939 |
| Q1 2021 | Parnassus Endeavor Fund | Sell | -260,004 | 314,412 | $87,957 |
| Q1 2021 | Hillman Value Fund | Buy | 7,360 | 27,289 | $7,634 |
| Q1 2021 | Muhlenkamp & Co | Buy | 37 | 18,184 | $6,361 |
| Q4 2020 | Renaissance Technologies LLC | Sell | -779,199 | 3,037,762 | $743,826 |
| Q4 2020 | Hillman Value Fund | Buy | 292 | 19,929 | $4,880 |
| Q4 2020 | Muhlenkamp & Co | Buy | 94 | 18,147 | $4,443 |
| Q3 2020 | Renaissance Technologies LLC | Sell | -88,961 | 3,816,961 | $1,082,795 |
| Q3 2020 | Hillman Value Fund | Buy | 3,391 | 19,637 | $5,571 |
| Q3 2020 | Hancock Classic Value | Sell | -386 | 2,857 | $810 |
| Q3 2020 | Muhlenkamp & Co | Buy | 222 | 18,053 | $5,121 |
| Q2 2020 | Renaissance Technologies LLC | Sell | -567,990 | 3,905,922 | $1,045,029 |
| Q2 2020 | First Eagle U.S. Value | Sell | -199,725 | 57,300 | $15,331 |
| Q2 2020 | Hancock Classic Value | Sell | -43,908 | 3,243 | $868 |
| Q2 2020 | Hillman Value Fund | Sell | -134 | 16,246 | $4,347 |
| Q2 2020 | Muhlenkamp & Co | Buy | 63 | 17,831 | $4,771 |
Frequently asked questions about BIIB activity
Which institutional owners are buying BIIB?
Institutional owners buying BIIB include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in BIIB activity?
"Buy" means an investor increased their reported position in BIIB compared to the prior reporting period. This reflects growing exposure to BIOGEN INC (BIIB) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in BIIB increasing?
Institutional interest in BIIB can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related BIIB insights
- BIIB Overview
- BIIB Institutions
- BIIB Institutional Ownership
- BIIB Top Shareholders
- BIIB Institutional Buying
- BIIB Institutional Selling
- BIIB Ownership Changes
- BIIB Insiders
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Owners in Q2 2026
- Most Sold Healthcare Stocks By Institutional Owners in Q2 2026
- Top Institutional Investor Stock Rankings